Stock screenerAll disclosures →
EDGAR →
NAMS
Conviction 0HealthcareScan · Mon, Aug 10, 2026Bullish harami
NAMS$28.02+0.20%
ResistanceSupportVol 14Insider sell2
Vol MA14 1.01M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price28.02
Change+0.20%
Gap+0.04%
Rel volume0.79×
Avg volume1.04M
Avg $ vol30.72M
SMA 2029.52
SMA 5031.31
SMA 20033.55
Price vs 50-10.53%
Price vs 200-16.51%
MA stackbearish
50/200 cross—
Supertrenddown · 31.95
RSI (14)39
MACD hist-0.10
MACD cross—
Stoch %K / %D33 / 31
ADX (14)37
+DI / −DI11 / 25
RSI divergence—
MACD divergenceBullish
ATR %+5.68%
ADR %5.43%
52w high41.45
52w low23.95
From 52w high-32.41%
Above 52w low+16.97%
New 52w highNo
SqueezeOff
Bollinger width25.56%
%B0.30
Donchian pos26.80%
Donchian high34.23
Donchian low25.74
AVWAP (52w high)32.70
vs AVWAP high-14.32%
AVWAP (52w low)33.58
vs AVWAP low-16.57%
OBV trendDown
Chaikin MF (20)-0.18
Today vs 20d0.79×
Avg vol (14d)1.01M
Avg vol (20d)1.04M
Avg $ vol (20d)30.72M
Market cap3.35B
RS 3m (vs SPY)-25.47%
RS 6m (vs SPY)-26.90%
RS line new highNo
Trend template0/8
Technical rank16.8
1 week+1.91%
1 month-20.55%
3 months-27.67%
6 months-18.32%
1 year+22.02%
YTD-20.41%
P/E-16.43
P/B5.30
P/S148.82
P/FCF-22.62
EPS-1.72
Div yield—
ROE-32.28%
ROA-28.93%
Debt/Eq—
Current9.03
EV/EBITDA-12.97
Gross margin—
Net margin-905.74%
Rev growth-50.61%
EPS growth15.64%
Price target53.29
Target upside90.22%
Analyst ratingBuy
Institutional103.87%
Ent. value2.92B
Revenue3.7M
Net income-64.14M
Gross profit—
Free cash flow-148.03M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out116.9M
Employees100
ListedWed, Nov 23, 2022
Free float62.23M
Float %53.2%
Short interest9.18M
Days to cover11.2d
Short volume70.3%
Squeeze score74 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.52 vs −$0.48
Last surprise-8.3% miss
Setup gradeD
Conviction0 / 100
Pattern quality—
Tech rank16.8 / 100
Group rank86 / 100 · Leading
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish harami
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in NAMS
No recent disclosed trades by Congress in NAMS. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in NAMS · 4 buys · 5 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Kooij Louise Frederika Chief Accounting Officer · Ordinary Shares · 2026-07-20 | Sell | 70.2K | $2.1M | 2026-07-20 | 2026-07-22 |
Kooij Louise Frederika Chief Accounting Officer · Ordinary Shares · 2026-07-20 | Sell | 31.89K | $990K | 2026-07-20 | 2026-07-22 |
Kooij Louise Frederika Chief Accounting Officer · Ordinary Shares · 2026-07-20 | Exercise | 25K | $298K | 2026-07-20 | 2026-07-22 |
Kooij Louise Frederika Chief Accounting Officer · Ordinary Shares · 2026-07-20 | Exercise | 80K | $894K | 2026-07-20 | 2026-07-22 |
Kooij Louise Frederika Chief Accounting Officer · Option (right to buy) · 2026-05-26 | Exercise | 5K | $0 | 2026-05-26 | 2026-05-27 |
Kooij Louise Frederika Chief Accounting Officer · Ordinary Shares · 2026-05-26 | Exercise | 5K | $55K | 2026-05-26 | 2026-05-27 |
Kooij Louise Frederika Chief Accounting Officer · Ordinary Shares · 2026-05-26 | Exercise | 60K | $600K | 2026-05-26 | 2026-05-27 |
Kooij Louise Frederika Chief Accounting Officer · Ordinary Shares · 2026-05-26 | Sell | 65K | $2.3M | 2026-05-26 | 2026-05-27 |
Kooij Louise Frederika Chief Accounting Officer · Option (right to buy) · 2026-05-26 | Exercise | 60K | $0 | 2026-05-26 | 2026-05-27 |
SEC filings
EDGAR filings in NAMS · 7 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.